Dmitry Balyasny’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
Other funds holding TARS
Dmitry Balyasny's TARS Position: Q3 2026 in Review
Dmitry Balyasny opened a new position in Tarsus Pharmaceuticals (TARS) in Q3 2026: 616,404 shares worth $48.5M. The stake represents 0.06% of the portfolio and ranks #387 among its holdings. This is a return to the name: Dmitry Balyasny previously reported a position in TARS as recently as Q2 2025.
Dmitry Balyasny first reported a position in TARS in Q1 2025 and has held it in 3 quarters since. 255 funds tracked by Wall St. Rank hold TARS as of Q3 2026.
- Dmitry Balyasny held 616,404 shares of Tarsus Pharmaceuticals worth $48.5M as of Q3 2026.
- Tarsus Pharmaceuticals was a new Dmitry Balyasny position in Q3 2026.
- Tarsus Pharmaceuticals made up 0.06% of Dmitry Balyasny's portfolio in Q3 2026, its #387 holding.
- Dmitry Balyasny first reported a position in Tarsus Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
- 255 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2026.
Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.